Open AccessRole of STK11 in ALK‑positive non‑small cell lung cancer (Review)
Author(s) -
Wen Zhou,
Lu-Da Yan,
Zhi-Qiong Yu,
Na Li,
Yonghua Yang,
Meng Wang,
Yuanyuan Chen,
Meng-Xia Mao,
Xiaochun Peng,
Jun Cai
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13301
Subject(s) - crizotinib , anaplastic lymphoma kinase , alectinib , ceritinib , medicine , lung cancer , stk11 , cancer research , erlotinib , targeted therapy , oncology , non small cell lung cancer (nsclc) , alk inhibitor , cancer , kras , epidermal growth factor receptor , colorectal cancer , a549 cell , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom